Deprecated: Assigning the return value of new by reference is deprecated in /f5/babybiotechs/public/wp-includes/cache.php on line 36

Deprecated: Assigning the return value of new by reference is deprecated in /f5/babybiotechs/public/wp-includes/query.php on line 15

Deprecated: Assigning the return value of new by reference is deprecated in /f5/babybiotechs/public/wp-includes/theme.php on line 505
Carnival of Biotechnology - March 27, 2007

Carnival of Biotechnology - March 27, 2007

Welcome to the March 27th version of the Carnival of Biotechnology. Thanks to Yali for letting me guest host the carnival. If you’d like to enter a post for a later edition or maybe even guest host, see the Carnival of Biotechnology submission and host information page.

Editor’s Picks

These weren’t submitted to the carnival, but I think they’re worth the read, so they get their own section:

If you haven’t read it yet, I have a post on whether Progression-free survival is a good end point to measure for clinical trials.

Wall Street Mayhem suggests two small biotech companies that might be good buys since they have a lot of cash.

Atlas Bioresearch has a long post on toll-like receptors and the companies that are trying to exploit them for the treatment of cancers, infectious diseases, asthma and allergies.

Finance and Business Development

Yali Friedman talks about how venture capital companies are decreasing their funding of startup biotechs and that angels are filling the biotechnology funding gap at Biotech Blog.  Now if I could only find some rich guy/gal (Angel) to do research for, I’d be a happy camper.
Derek Lowe discusses the future of Atherogenics’ drug AGI-1067 which failed its phase 3 trial in his post AGI-1067: Dead or Alive? at In the Pipeline.

Christopher Depelteau has a post describing FoxHollow Technologies’ SilverHawk™ Plaque Excision System at MRI LINKS AND OTHER COOL THINGS.

Regulations and Politics

David Williams has a suggestion for the Senators on the Health, Education, Labor and Pensions Committee about how to keep the price of biologics low but still safe in his post Senators still seem to be missing the point on generic biologics at Health Business Blog.

Yali Friedman talks about the clash between governments need for reasonably priced drugs during “crises” and companies’ desire to defend their patents and make money in his post Price controls and compulsory licensing give buyers more power … for a price at Biotech Blog.

Science

Attila Csordas has a proposal for the beloved section of the scientific paper that doesn’t make it into the journal, but is (sometimes) worth looking at: Let’s make ’supplementary’ peer-review scientific videos free and youtubish! posted at Pimm - Partial immortalization.

Barry Mahfood compares “nanomachines” to protein machines that act in our cells in his post Do You Believe in Nanomachines? You Should at The Price of Rice!.

John posts a basic explanation of genes, sequencing, and how it may lead to more specialized medicine in his post DNA And BioTechnology Allows You To live Forever at OhCash.com.

And that concludes this week’s carnival.  If you’re interested in investing in stocks, I’ve got a post in the Festival of Stocks.  I think I was the only biotechnology stock, but then again, you’re not investing in just biotechs, are you?  Go have a read once you’re done with this weeks carnival.

16 Responses to “Carnival of Biotechnology - March 27, 2007”

  1. Great Job! Thanks for hosting.

  2. […] of Biotechnology The latest Carnival of Biotechnology is up at Baby Biotechs. Great job, […]

  3. […] out the Carnival of Biotechnology at Baby Biotechs. +del.icio.us +Digg […]

  4. […] niche blog world to get well connected and widely read is hosting topic restricted Carnivals. The recent Carnival of Biotechnology is hosted on Babybiotechs and is rather industry and business oriented which is a good sign of a […]

  5. Interesting carnival. Blog Carnival just keeps growing and growing. I’ll try to submit something next week.

  6. […] Carnival of Biotechnology - March 27, 2007 (tags: biotech stocks) […]

  7. Some kind of scientific performance? Nice idea.

  8. *applauds*

  9. I have to say, I enjoy reading this blog. Could tell me how I can keeping up to date with it? By the way I discovered this blog through Google.

  10. dobry biznes plan

  11. Hello, I want to accord you solitary of my most qualified pages connected with pozycjonowanie stron www - http://pozycjonowanie.art4web.pl - pozycjonowanie.

    It discretion be non-standard real wares suited for me if you will be able to go it!

  12. Are you the proprietress of our solutions are in search you. We take planned an smashing program in compensation HR and payroll płace (płace). Wages of employees, information fro the unalloyed determine, payroll in all and sundry arise and enthusiastic immediately. Visualize how much you insufficiency to in a indispensable and affordable kidney to mastery the ensemble gear enterprise. The thickheadedness of our software maximizes its use.

  13. przeprowadzki

  14. 5. Choroba ta moze pozostawac nierozpoznana do okresu pokwitania. Ciaza, ktorych matki pily alkohol w czasie ciazy sa obarczone tzw. ciaza
    . Musi takze pamietac o prawidlowym odzywianiu sie, jako ze szybko rosnace.

  15. It’s truly a nice and helpful piece of info. I am glad that you shared this useful information with us. Please keep us informed like this. Thanks for sharing.

  16. A persons Have been normally Weight loss is definitely
    a practical and flexible an eating plan tactic manufactured for those who suffer
    that would just like to weight loss and therefore
    ultimately conserve a much more culture. weight loss

Leave a Reply